Stockreport
3 Magnificent Stocks Retirees Can Buy and Hold Forever [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Three Motley Fool contributors think they've found magnificent stocks retirees can buy and hold forever. Here's why they picked AbbVie (NYSE: ABBV) Gilead Sciences (NASDAQ: GILD) , and Johnson & Johnson (NYSE: JNJ) A Dividend King poised for growth Keith Speights (AbbVie) : There's arguably no group of stocks better suited for retirees than the Dividend Kings. These stocks have increased their dividends for at least 50 consecutive years. AbbVie is a member of dividend royalty thanks to its track record of 52 years in a row of dividend hikes. Some Dividend Kings offer paltry dividend yields, but not AbbVie. The big drugmaker's dividend payout has soared nearly 45% over the last five years, with its yield currently hovering around 3.7%. Even better, AbbVie is poised for solid growth. That might be surprising considering that sales are sinking for the company's top-selling drug, Humira, in the face of biosimilar competition. However, AbbVie has a strong stable of newer products
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- NACD Announces 10 Finalists for the 2024 DE&I Awards [Yahoo! Finance][Yahoo! Finance]
- Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE? [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences, Inc. (NASDAQ: GILD) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $74.00 price target on the stock.[MarketBeat]
- Should You Hold Gilead Sciences (GILD)? [Yahoo! Finance][Yahoo! Finance]
- NEW DATA SUPPORT THE USE OF BICTEGRAVIR TABLET REGIMEN TO TREAT PEOPLE WITH HIV AND INDIVIDUALS WITH HIV/HBV-COINFECTION IN ASIA [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 7/1/24 - Form 4
- 7/1/24 - Form 144
- 6/11/24 - Form 4
- GILD's page on the SEC website
- More